lower volumes, price holding ground...sort of. May have the legs to get into second gear once the RSI has cooled back below 70. Was still at 78 at yesterday's close.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%